Published in Can J Cardiol on September 22, 2011
A new paradigm for primary prevention strategy in people with elevated risk of stroke. Int J Stroke (2014) 0.86
Prevention of stroke: a strategic global imperative. Nat Rev Neurol (2016) 0.76
Perceived Preparedness of Health Care Students for Providing Cardiovascular Disease Risk Assessment and Management. Pharmacy (Basel) (2017) 0.75
Changes in diabetes self-care behaviors make a difference in glycemic control: the Diabetes Stages of Change (DiSC) study. Diabetes Care (2003) 1.76
The 2004 ACC/AHA Guidelines: a perspective and adaptation for Canada by the Canadian Cardiovascular Society Working Group. Can J Cardiol (2004) 1.72
The regionalization of pediatric health care. Pediatrics (2010) 1.46
Treating the right patient at the right time: Access to cardiac catheterization, percutaneous coronary intervention and cardiac surgery. Can J Cardiol (2006) 1.22
Applying the new STEMI guidelines: 1. Reperfusion in acute ST-segment elevation myocardial infarction. CMAJ (2004) 1.17
Universal access -- but when? Treating the right patient at the right time: access to electrophysiology services in Canada. Can J Cardiol (2006) 1.02
Bridging the gap between primary and secondary care: use of a clinical pathway for the investigation and management of deep vein thrombosis. J Health Serv Res Policy (2008) 0.93
The consequences of anxious temperament for disease detection, self-management behavior, and quality of life in Type 2 diabetes mellitus. J Psychosom Res (2009) 0.93
Contemporary comparison of surgical and interventional arteriography management of blunt renal injury. J Vasc Interv Radiol (2011) 0.93
Anxious temperament and disease progression at diagnosis: the case of type 2 diabetes. Psychosom Med (2008) 0.91
Impact of the fall 2009 influenza A(H1N1)pdm09 pandemic on US hospitals. Med Care (2013) 0.90
Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Atherosclerosis (2008) 0.88
Realigning reimbursement policy and financial incentives to support patient-centered out-of-hospital care. JAMA (2013) 0.88
Sepsis: the inflammatory foundation of pathophysiology and therapy. Hosp Pract (1995) (2011) 0.85
Improved prediction of early-onset coronary artery disease using APOE epsilon4, BChE-K, PPARgamma2 Pro12 and ENOS T-786C in a polygenic model. Clin Biochem (2005) 0.82
Relation between butyrylcholinesterase K variant, paraoxonase 1 (PON1) Q and R and apolipoprotein E epsilon 4 genes in early-onset coronary artery disease. Clin Biochem (2002) 0.82
Benchmarking the incidence of organ failure after injury at trauma centers and nontrauma centers in the United States. J Trauma Acute Care Surg (2013) 0.81
Outcomes following percutaneous coronary intervention and coronary artery bypass grafting surgery in Chinese, South Asian and White patients with acute myocardial infarction: administrative data analysis. BMC Cardiovasc Disord (2013) 0.81
Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial. Stroke (2009) 0.81
Clinician-performed Beside Ultrasound for the Diagnosis of Traumatic Pneumothorax. West J Emerg Med (2013) 0.80
Creating integrated networks of emergency care: from vision to value. Health Aff (Millwood) (2013) 0.80
A novel approach to cardiovascular health by optimizing risk management (ANCHOR): behavioural modification in primary care effectively reduces global risk. Can J Cardiol (2013) 0.80
Oral Anticoagulation for Stroke Prevention in Canadian Practice: Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry(.). Can J Cardiol (2015) 0.80
The Healthy LifeWorks Project: a pilot study of the economic analysis of a comprehensive workplace wellness program in a Canadian government department. J Occup Environ Med (2011) 0.78
Postpartum flatal and Fecal Incontinence Quality-of-Life Scale: a disease- and population-specific measure. Qual Health Res (2003) 0.77
Medical wait lists. CMAJ (2006) 0.75
Enoxaprin may be more effective than unfractionated heparin for people with high-risk non ST-segment elevation acute coronary syndromes. Evid Based Cardiovasc Med (2006) 0.75
Improved wait times for coronary revascularization: cause to celebrate spotting the iceberg in time or time to look under the surface? Can J Cardiol (2011) 0.75
Timely access to acute cardiac care: can it overcome a lifetime of despair? Can J Cardiol (2011) 0.75
Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatment. Can J Cardiol (2006) 0.75
Applying the new STEMI guidelines: 2. Disturbances of cardiac rhythm after ST-segment elevation myocardial infarction. CMAJ (2004) 0.75
Canadian Cardiovascular Society Quality Indicators for Heart Failure. Can J Cardiol (2015) 0.75
The Canadian Cardiovascular Society thanks Pulsus Group. Can J Cardiol (2010) 0.75
Teaching status: the impact on emergency and elective surgical care in the US. Ann Surg (2011) 0.75
Measure twice, cut once: achieving consensus on data definitions and quality indicators in Canada. Can J Cardiol (2012) 0.75
Minimizing the urological and psychological morbidity of urinary tract fistulae from VBAC. J Obstet Gynaecol Can (2006) 0.75
Weekend compared with weekday presentation does not affect outcomes of patients presenting with non-ST elevation acute coronary syndrome. Eur Heart J Acute Cardiovasc Care (2013) 0.75
Executive summary -- 2010 consensus conference. Acad Emerg Med (2010) 0.75
The Healthy LifeWorks project: The effect of a comprehensive workplace wellness program on the prevalence and severity of musculoskeletal disorders in a Canadian government department. J Occup Environ Med (2013) 0.75
Statin therapy and the management of acute coronary syndromes. Can J Cardiol (2003) 0.75
Performance of the timed "up & go" test in spinal muscular atrophy. Muscle Nerve (2014) 0.75